Synthesis of pyrrolo[2,3-d]pyrimidine nucleoside derivatives as potential anti-HCV agents

Mutagenic effects of ribavirin and response to interferon/ribavirin combination therapy in chronic hepatitis C

Yasuhiro Asahina, Namiki Izumi, Nobuyuki Enomoto et al. · Journal of Hepatology · 2005 · 114 citations

Medicine, Pharmacology, Toxicology +16

Synthesis, cytotoxicity, and antiviral activity of some acyclic analogs of the pyrrolo[2,3-d]pyrimidine nucleoside antibiotics tubercidin, toyocamycin, and sangivamycin

Pranab K. Gupta, Sylvia Daunert, Mahmoud Nassiri et al. · Journal of Medicinal Chemistry · 1989 · 70 citations

Medicine, Medicinal Chemistry, Pharmacology +13

Nucleic acid related compounds. 51. Synthesis and biological properties of sugar-modified analogs of the nucleoside antibiotics tubercidin, toyocamycin, sangivamycin, and formycin

Erik De Clercq, Jan Balzarini, Danuta Madej et al. · Journal of Medicinal Chemistry · 1987 · 67 citations

Pharmacy, Medicinal Chemistry, Pharmacology +7

Enhancement of antiviral activity against hepatitis C virus in vitro by interferon combination therapy

Chiaki Okuse, Jo Ann Rinaudo, Kristine Farrar et al. · Antiviral Research · 2004 · 65 citations

Medicine, Immunology, Infectious Diseases +13

Canonical 3′-deoxyribonucleotides as a chain terminator for HCV NS5B RNA-dependent RNA polymerase

Jaehoon Shim, Gabry Larson, Vicky C. H. Lai et al. · Antiviral Research · 2003 · 49 citations

Life Sciences, Biology, Molecular Biology +16